Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Naldini

Showing results (1-10 of 262) with videos related to

Pageof 27
Sort By:
Nature Reviews. Genetics|March 30, 2011
Ex vivo gene transfer and correction for cell-based therapiesLuigi Naldini
Nature|October 16, 2015
Gene therapy returns to centre stageLuigi Naldini
EMBO Molecular Medicine|January 24, 2019
Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectivesLuigi Naldini
Science (New York, N.Y.)|November 7, 2009
Medicine. A comeback for gene therapyLuigi Naldini
Nature Medicine|April 7, 2006
Inserting optimism into gene therapyLuigi Naldini
Methods in Enzymology|March 9, 2002
Generation of HIV-1 derived lentiviral vectorsAntonia Follenzi, Luigi Naldini
Cell Stem Cell|November 10, 2019
In Vivo Selection for Gene-Corrected HSPCs Advances Gene Therapy for a Rare Stem Cell DiseaseBernhard Gentner, Luigi Naldini
Human Gene Therapy|April 23, 2015
Fighting rare diseases: the model of the telethon research institutes in ItalyAndrea Ballabio, Luigi Naldini
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 16, 2020
WFH State-of-the-art paper 2020: In vivo lentiviral vector gene therapy for haemophiliaAlessio Cantore, Luigi Naldini
Nature Biotechnology|July 13, 2016
Safer conditioning for blood stem cell transplantsAlessandro Aiuti, Luigi Naldini
Pageof 27

Showing results (1-10 of 262) with videos related to

Sort By:
Pageof 27
Nature Reviews. Genetics|March 30, 2011
Ex vivo gene transfer and correction for cell-based therapiesLuigi Naldini
Nature|October 16, 2015
Gene therapy returns to centre stageLuigi Naldini
EMBO Molecular Medicine|January 24, 2019
Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectivesLuigi Naldini
Science (New York, N.Y.)|November 7, 2009
Medicine. A comeback for gene therapyLuigi Naldini
Nature Medicine|April 7, 2006
Inserting optimism into gene therapyLuigi Naldini
Methods in Enzymology|March 9, 2002
Generation of HIV-1 derived lentiviral vectorsAntonia Follenzi, Luigi Naldini
Cell Stem Cell|November 10, 2019
In Vivo Selection for Gene-Corrected HSPCs Advances Gene Therapy for a Rare Stem Cell DiseaseBernhard Gentner, Luigi Naldini
Human Gene Therapy|April 23, 2015
Fighting rare diseases: the model of the telethon research institutes in ItalyAndrea Ballabio, Luigi Naldini
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 16, 2020
WFH State-of-the-art paper 2020: In vivo lentiviral vector gene therapy for haemophiliaAlessio Cantore, Luigi Naldini
Nature Biotechnology|July 13, 2016
Safer conditioning for blood stem cell transplantsAlessandro Aiuti, Luigi Naldini
Pageof 27